跳至主要内容
临床试验/CTRI/2024/05/066990
CTRI/2024/05/066990尚未招募3 期

A comparative randomized clinical study to evaluate the efficacy of Nitya Virechana with Trivrita kwatha and Aaragvadha Kwatha in the management of Madhumeha (Diabetes mellitus II)

Ch. Brahm Prakash Ayurved Charak Sansthan1 个研究点 分布在 1 个国家目标入组 56 人开始时间: 2024年5月20日最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方
入组人数
56
试验地点
1
主要终点
Nitya Virechana Karma with Trivrita Kwatha may show better results on maintaining the blood glucose level in comparison to Nitya Virechana with Aragvadha Kwatha.

研究概览

简要总结

The study is comparative randomized clinical study to evaluate the efficacy of Nitya Virechana with Aaragvadha Kwatha and Trivrita Kwatha in management of Madhumeha (Diabetes mellitus â…¡). In one group Trivrita kwatha 60ml will be given daily for 21 day and follow up done on 42th day. In another group Aaragavadha kwatha 60ml will be given daily for 21 day and again follw up done on 42th day. The trial will be conducted in Ch. brahm prakash ayurved charak sansthan with outcome ; nitya virecahana with Trivrita kwatha may show better efficacy than nitya virechana with Aaragvadha in the management of madhumeha in improving FBS and PPBS value and other associated symptoms.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
None

入排标准

年龄范围
32.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • 1.Newly diagnosed patients of Diabetes mellitus type-2 2.Patient fit for virechan 3.Patient who is taking or not taking medicines. 4.Patient whose blood sugar level comes in range as follows- FBS.
  • 120-180mg/dl, PPBS- 150-250mg/dl.

排除标准

  • 1.Insulin dependent diabetes mellitus or those who are under insulin therapy.
  • 2.Patients with chronic diabetic complications like nephropathy, neuropathy and retinopathy.
  • 3.Patients with severe systemic diseases like HIV, Cancer, Hepatitis etc.
  • 4.Pregnant and lactating women.

结局指标

主要结局

Nitya Virechana Karma with Trivrita Kwatha may show better results on maintaining the blood glucose level in comparison to Nitya Virechana with Aragvadha Kwatha.

时间窗: 0,1,14,21,42th day

次要结局

  • Nitya Virechana Karma with Trivrita Kwatha may show better results on maintaining the blood glucose level in comparison to Nitya Virechana with Aragvadha Kwatha(21 day)

研究者

发起方
Ch. Brahm Prakash Ayurved Charak Sansthan
申办方类型
Government medical college
责任方
Principal Investigator
主要研究者

Dr Rakesh Kumar Majhi

Chaudhary Brahm Prakash Ayurved Charak Sansthan, Kheradabar, Najafgarh, New delhi

研究点 (1)

Loading locations...

相似试验